Inhalation Wednesday, April 25, 2018
Skip Navigation LinksHome) Item Details
Inhalation is the only technical publication devoted exclusively to readers involved in development and production of pulmonary or nasal delivered pharmaceuticals.
General Articles
CROs and OINDP development

Why you may want to integrate a contract research organization into the development process of your orally inhaled product (OIP).

Significant delays in product development can occur during the characterization process due to the need to solve scientific problems or because of resource limitations when staff or equipment requirements exceed what the sponsor site has available. As a result, a pharmaceutical company investigating a new orally inhaled drug (may benefit by integrating a contract research organization (CRO) into the development process to supplement the basic analytical expertise available in the sponsor laboratory. The spectrum of offerings from various CROs encompasses the entire range of activities for OIP product development, and sponsors also have the option of working in parallel with a CRO on various activities.

To read this entire article:

You may purchase this article now for personal use. Simply click the Buy Item button above, enter your payment details, and download the article. It will be available to you for 7 days for viewing, printing, or saving for future reference. All articles are copyrighted by CSC Publishing, Inc. and cannot be used for commercial purposes without express permission in writing from the Publisher. This includes but is not limited to: web posting, printing, or sharing via email.


Your payment information is forwarded in an encrypted form, using 40- or 128-bit Secure Socket Layer technology, only to our payment gateway ( for processing.


To view an article, you must have Acrobat Reader installed on your computer. Click on the icon to download Acrobat Reader free of charge.

      Copyright 2018, CSC Publishing Inc. ALL Rights Reserved * Privacy policy